A review of 45 studies (28 interventional) showed that telemedicine for congestive heart failure has not yet met policy expectations due to excessive heterogeneity and methodological insufficiencies.
Does telemedicine improve patient outcomes, lower costs, and achieve high acceptance in patients with congestive heart failure?
Current evidence on telemedicine for CHF is too heterogeneous to definitively confirm policy expectations of improved outcomes, lower costs, and high acceptance.
A critical review of evidence was carried out to discover whether the actual performance of telemedicine fulfils the expectations of German policy-makers. The analysis was conducted using the example of telemedicine for congestive heart failure (CHF). It was based on both German and international evidence. The PubMed, MEDLINE, Google Scholar and Cochrane Library databases were searched, as well as public sources from the German Federal Ministry of Health. Forty-five studies reporting patient outcomes, costs or acceptance of telemedicine for CHF were included in the review, of which 28 were interventional. The policy expectations of telemedicine generally are: high technology acceptance and improved patient outcomes at lower costs. However, in the field of CHF, policy-makers underestimate the complexity of telemedicine and the technology has not yet lived up to its expectations. Although some studies show improvements in all-cause mortality and CHF-related hospitalisations, there is excessive study heterogeneity and vagueness in the areas of costs and acceptance. Methodological insufficiencies as well as the scarcity of evidence in the German context do not allow definite conclusions to be drawn. Policy-makers and other stakeholders should increase their efforts to consolidate isolated telemedicine projects, establish guidelines for clinical treatment procedures and economic evaluations, and define industry/technical device standards to enhance the comparability of interventions. Imposing the use of telemedicine on patients and physicians is not likely to be fruitful. A successful adaptation requires an analysis of needs and continuous education on both sides.
Dmitrij Achelrod (Tue,) conducted a review in congestive heart failure. Telemedicine was evaluated on patient outcomes, costs, and acceptance. A review of 45 studies (28 interventional) showed that telemedicine for congestive heart failure has not yet met policy expectations due to excessive heterogeneity and methodological insufficiencies.